.

Deeper Knowledge, Faster

  • Identify first generic entrants
  • Uncover prior art in expired and abandoned patents
  • Obtain formulation and manufacturing information

► See Plans and Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving 500+ biopharmaceutical companies globally:

Colorcon
Accenture
Deloitte
Baxter
Farmers Insurance
Cerilliant
US Army
Johnson and Johnson
Covington
Fuji

Generated: June 23, 2017

DrugPatentWatch Database Preview

Ivabradine hydrochloride - Generic Drug Details

« Back to Dashboard

What are the generic sources for ivabradine hydrochloride and what is the scope of ivabradine hydrochloride patent protection?

Ivabradine hydrochloride
is the generic ingredient in one branded drug marketed by Amgen Inc and is included in one NDA. There are five patents protecting this compound. Additional information is available in the individual branded drug profile pages.

Ivabradine hydrochloride has ninety-one patent family members in forty-one countries.

There are two drug master file entries for ivabradine hydrochloride. One supplier is listed for this compound.

Summary for Generic Name: ivabradine hydrochloride

Tradenames:1
Patents:5
Applicants:1
NDAs:1
Drug Master File Entries: see list2
Suppliers / Packagers: see list1
Bulk Api Vendors: see list47
Clinical Trials: see list2,283
Patent Applications: see list122
Drug Prices:see low prices
DailyMed Link:ivabradine hydrochloride at DailyMed
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Amgen Inc
CORLANOR
ivabradine hydrochloride
TABLET;ORAL206143-001Apr 15, 2015RXYesNo7,361,649► SubscribeYY ► Subscribe
Amgen Inc
CORLANOR
ivabradine hydrochloride
TABLET;ORAL206143-001Apr 15, 2015RXYesNo7,879,842► SubscribeYY ► Subscribe
Amgen Inc
CORLANOR
ivabradine hydrochloride
TABLET;ORAL206143-002Apr 15, 2015RXYesYes7,361,649► SubscribeYY ► Subscribe
Amgen Inc
CORLANOR
ivabradine hydrochloride
TABLET;ORAL206143-002Apr 15, 2015RXYesYes► Subscribe► Subscribe
Amgen Inc
CORLANOR
ivabradine hydrochloride
TABLET;ORAL206143-001Apr 15, 2015RXYesNo7,361,650► SubscribeYY ► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

International Patent Family for Ingredient: ivabradine hydrochloride

Country Document Number Estimated Expiration
World Intellectual Property Organization (WIPO)2006092493► Subscribe
China100402502► Subscribe
Peru11422006► Subscribe
South Korea20060095499► Subscribe
Cuba23614► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

The estimated expiration dates shown above are derived by simply adding 20 years to the priority date.
Due to the complexity of determining patent expirations even in a single country, compounded by the diversity of global patent laws, it is advisable to have patent counsel verify freedom to operate.

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving 500+ biopharmaceutical companies globally:

Citi
McKesson
Queensland Health
Fish and Richardson
Johnson and Johnson
QuintilesIMS
Chubb
Julphar
Boehringer Ingelheim
Cipla

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot